REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$7.51
-7.79%
Mkt Cap $415.13M
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (25 analysts)
$19.14
Range $12.00 – $32.00
Implied Upside
+154.9%
Consensus $19.14 vs current $7.51
NASDAQ·Healthcare·Biotechnology
$7.51
-7.79%
Mkt Cap $415.13M
Buy
9
Hold
1
Sell
0
Price Target (25 analysts)
$19.14
Range $12.00 – $32.00
+154.9%
Consensus $19.14 vs current $7.51